Montelukast Prescribing at ROYAL CRESCENT SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
808
Total Quantity
21.9K
NHS Cost
£1.1K
vs National Avg
+18%
ROYAL CRESCENT SURGERY prescribed 808 items of Montelukast over the last 12 months at a cost of £1,074 to the NHS. This is 18% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
72
Jul 2026
59
Jul 2026
64
Jul 2026
70
Jul 2026
66
Jul 2026
61
Jul 2026
62
Jul 2026
73
Jul 2026
91
Jul 2026
55
Jul 2026
70
Jul 2026
65
Prescribing Details
| Total Items | 808 |
|---|---|
| Total Quantity | 21,911 |
| Total NHS Cost | £1,074 |
| Presentations | 3 different forms |
| vs National Average | +18% |
Montelukast Prescribing Comparison
| This practice | 808 items |
|---|---|
| National average per practice | 685 items |
| Difference | +18% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.